Inflammatory Bowel Disease (Irritable Bowel Syndrome): Epidemiology Forecasting Intelligence
![](/report_cover/11052/inflammatory-bowel-disease-irritable-bowel-syndrome-epidemiology-forecasting-intelligence_en.gif)
CmaxInsight’s “Inflammatory Bowel Disease (Irritable Bowel Syndrome)-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.
Our epidemiology services include:
Our epidemiology services include:
- Incidence and prevalence
- Diagnosis rate, treatment rate and mortality patterns
- Epidemiology-based forecasting and disease trends
- Size of different patient segments in a disease area
- Population based: disease occurrence, co-morbidities and treatment patterns
- Geographic - Regional - Ethnic differences
- Disease overview, causes, symptoms, classification, risk factor, pathophysiology, diagnosis and treatment
- Patient treatment journey
- Treatment algorithm and guidelines
- Assesses the disease risk and burden
- Highlights the unmet needs
- Market driver and barrier
- Growth opportunities and market trend analysis
- This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Epidemiology Forecast model analysis by a team of industry experts.
- To generate accurate patient population estimates, utilizes a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
- All of the sources used to generate the data and analysis have been identified in the report.
1. REPORT INTRODUCTION
2. INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME) EPIDEMIOLOGY OVERVIEW AT A GLANCE
3. MARKET SHARE DISTRIBUTION OF INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME)
4. DISEASE BACKGROUND AND OVERVIEW: INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME) EPIDEMIOLOGY
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME) BY COUNTRIES
7. UNITED STATES
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
7.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
7.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
7.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
7.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.1.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.1.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.1.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.1.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.2.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.2.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.2.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.2.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.3.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.3.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.3.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.3.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.4.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.4.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.4.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.4.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.5.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.5.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.5.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.5.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
9. JAPAN
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
9.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
9.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
9.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
9.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
10. UNMET NEEDS
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.
2. INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME) EPIDEMIOLOGY OVERVIEW AT A GLANCE
3. MARKET SHARE DISTRIBUTION OF INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME)
4. DISEASE BACKGROUND AND OVERVIEW: INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME)
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME) EPIDEMIOLOGY
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE (IRRITABLE BOWEL SYNDROME) BY COUNTRIES
7. UNITED STATES
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
7.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
7.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
7.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
7.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.1.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.1.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.1.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.1.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.2.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.2.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.2.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.2.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.3.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.3.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.3.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.3.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.4.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.4.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.4.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.4.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.5.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.5.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
8.5.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
8.5.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
9. JAPAN
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
9.3. Sub-Type Specific cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
9.4. Sex- Specific Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)*
9.5. Diagnosed Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
9.6. Treated Cases of Inflammatory Bowel Disease (Irritable Bowel Syndrome)
10. UNMET NEEDS
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific
Note: Certain sections of the table of contents would vary according to the availability of information.
LIST OF TABLES
Table 1: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM
Table 2: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Table 4: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Table 5: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Table 6: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Table 7: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Table 8: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Table 9: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Table 10: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Table 11: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Table 12: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Table 13: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Table 14: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Table 15: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Table 16: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Table 17: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Table 18: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Table 19: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Table 20: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Table 21: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Table 22: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Table 23: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Table 24: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Table 25: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Table 26: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Table 27: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Table 28: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Table 29: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Table 30: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Table 31: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Table 32: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Table 33: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Table 34: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Table 35: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Table 36: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Table 37: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM
Table 2: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Table 4: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Table 5: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Table 6: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Table 7: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Table 8: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Table 9: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Table 10: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Table 11: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Table 12: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Table 13: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Table 14: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Table 15: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Table 16: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Table 17: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Table 18: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Table 19: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Table 20: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Table 21: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Table 22: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Table 23: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Table 24: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Table 25: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Table 26: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Table 27: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Table 28: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Table 29: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Table 30: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Table 31: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Table 32: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Table 33: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Table 34: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Table 35: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Table 36: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Table 37: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
*Indication Specific
LIST OF FIGURES
Figure 1: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Figure 4: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Figure 5: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Figure 6: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Figure 7: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Figure 8: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Figure 9: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Figure 10: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Figure 11: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Figure 12: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Figure 13: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Figure 14: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Figure 15: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Figure 16: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Figure 17: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United France
Figure 18: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Figure 19: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Figure 20: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Figure 21: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Figure 22: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Figure 23: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Figure 24: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Figure 25: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Figure 26: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Figure 27: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Figure 28: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Figure 29: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Figure 30: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Figure 31: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Figure 32: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Figure 33: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Figure 34: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Figure 35: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Figure 36: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Figure 37: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
*Indication Specific
Figure 1: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Figure 4: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Figure 5: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States*
Figure 6: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Figure 7: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United States
Figure 8: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Figure 9: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Figure 10: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany*
Figure 11: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Figure 12: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Germany
Figure 13: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Figure 14: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Figure 15: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France*
Figure 16: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in France
Figure 17: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in United France
Figure 18: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Figure 19: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Figure 20: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy*
Figure 21: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Figure 22: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Italy
Figure 23: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Figure 24: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Figure 25: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain*
Figure 26: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Figure 27: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Spain
Figure 28: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Figure 29: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Figure 30: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK*
Figure 31: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Figure 32: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in UK
Figure 33: Prevalent/Incident Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Figure 34: Sub-Type Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Figure 35: Sex- Specific Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan*
Figure 36: Diagnosed Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
Figure 37: Treated Cases of the Inflammatory Bowel Disease (Irritable Bowel Syndrome) in Japan
*Indication Specific